HUNTER-FLEMING

Welcome to the Brand page for “HUNTER-FLEMING”, which is offered here for Pharmaceutical, medicinal, biological and chemical preparations for the treatment of cancers, auto immune diseases, peripheral neuropathies, pain, chronic neurodegenerative diseases, peripheral neuropathies, acute neurological degenerative conditions, peripheral arterial diseases, coronary artery diseases, myocardial infarction, cerebrovascular diseases, liver and kidney ischaemia, diabetes, vascular diseases of the kidney, obesity, inflammatory airways diseases, inflammatory bowel disease, chrone's disease, inflammatory diseases characterized by degeneration of articular cartilage, wound healing, toxicity and peripheral neuropathies caused by chemotherapeutic agents, inflammatory skin conditions, motor neuron disease, metabolic syndrome x, acromegaly, bone diseases; veterinary preparations for the treatment of neurodegenerative and inflammatory diseases in domestic animals and livestock; diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing for medical, pharmaceutical and veterinary purposes;scientific and technological services, medical and scientific research services in the field of neurodegenerative and inflammatory disorders; research and development of medical, pharmaceutical and veterinary products; medical, pharmaceutical and veterinary product development; clinical product development of chemical and biological products for pharmaceutical, medical and veterinary purposes; medical and scientific research, clinical trials; new drug design and development;.

Its status is currently believed to be active. Its class is unavailable. “HUNTER-FLEMING” is believed to be currently owned by “Hunter-Fleming Limited”.